Breast Health Insights: Investigating High Breast Parenchymal Enhancement Volume and its Association with Elevated Cancer Risk

Instead of solely focusing on breast density as a risk factor, the study encourages consideration of other properties of the breast, as revealed through the initial screening MRI. This personalized approach could potentially revolutionize breast cancer screening methods, making them more effective and efficient in identifying and addressing breast cancer risk.

In a recent study, researchers have uncovered a potential connection between breast parenchymal enhancement (BPE) volume and the likelihood of developing breast cancer. The study, conducted as part of the Dense Tissue and Early Breast Neoplasm Screening (DENSE) Trial, examined over 4,500 participants to investigate how BPE could serve as an indicator of breast cancer risk.

 

The DENSE Trial involved women who underwent dynamic contrast-enhanced MRI exams at eight hospitals in the Netherlands between December 2011 and January 2016. The researchers harnessed the power of deep learning technology to automatically identify fibroglandular tissue within the breast, using the MRI data.

 

After considering factors such as age, BMI, and BPE, the researchers made an interesting discovery. They found that women with higher volumes of enhancing parenchyma – the tissue that fills the breast and includes glandular and connective tissue – had a higher chance of suffering from breast cancer compared to those with lower volumes of enhancing parenchyma.

 

Out of the 4,553 women who participated in the study, 122 were diagnosed with breast cancer. Impressively, approximately 63% of these cases were detected after the first round of screening. For the remaining women diagnosed with breast cancer, the average time for cancer detection was around 24 months.

 

Dr. Gilhuijs, one of the researchers, explained that the process of enhancement is not uniform across all parts of the breast when viewed through MRI. The method used in this study involved calculating and sorting the different subvolumes of the enhancing parenchyma, ranking them from high to low based on enhancement patterns.

 

While the study sheds light on the potential of BPE volume as an indicator for breast cancer risk, it also brings attention to the challenges that arise from this new insight. While implementing supplemental MRI screenings for women with dense breasts could lead to a reduction in interval cancers, it may also place an additional workload on radiologists. To address this, researchers suggest the need for personalized strategies that can manage the increased number of screenings and ease the strain on the healthcare system.

 

Dr. Gilhuijs highlighted the importance of this study as a first step towards tailoring the frequency of MRI screenings for women with dense breasts. Instead of solely focusing on breast density as a risk factor, the study encourages consideration of other properties of the breast, as revealed through the initial screening MRI. This personalized approach could potentially revolutionize breast cancer screening methods, making them more effective and efficient in identifying and addressing breast cancer risk.

Tags : #Breastcancer #breasthealth #womenshealth #doctorsinsights #womendevelopment

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024
Are we on the path to end AIDS by 2030?October 03, 2024
TTK Prestige Announces Shubhutsav- A Special Festive Offer, Elevating Home CookingOctober 03, 2024
Tata Soulfull Launches Tata Soulfull Corn Flakes+, With the Goodness of Millets in Every Flake October 03, 2024
The Bitter Truth Behind Sweet Treats: Hidden Cancer Risks in Your Favorite CakesOctober 03, 2024
Ageing Faster Than You Think? Discover How a Simple Cheek Swab Could Save Your LifeOctober 03, 2024
The University of Tasmania invites international student applications for their Tasmanian International ScholarshipOctober 03, 2024
A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin BlockersOctober 03, 2024
Prostate Cancer Strikes Young: The Alarming Rise of Aggressive Cases in Men Under 50October 03, 2024
Fleetguard Filters Private Limited (FFPL) Wins Prestigious ‘Iconic Brands of India 2024’ at the This recognition adds to Fleetguard's growing list of accolades, further establishing its position as a leader in the automotive industry. The company remains dedicated to advancing innovation and providing solutions that consistently meet the changing needs of its customers.October 03, 2024
Marico’s Saffola Honey and Pankaj Tripathi Uncover the Secret of Shuddha Honey in its latest TVCOctober 01, 2024
Mr. Piush Srivastava, Head of Marketing and Corporate Communications of Fleetguard Filters Pvt. Ltd, Awarded 'Marketing Maverick' by Dun & Bradstreet October 01, 2024
Chikungunya Strikes Back: The Forgotten Virus Making a Deadly ComebackOctober 01, 2024
The Hidden Cancer Risk in Your Morning Routine: How Poor Oral Hygiene May Be Endangering Your HealthOctober 01, 2024